drugset / Trial / NCT04187625
Cell-based Therapy for the Treatment of Kidney Disease
NaSingle-groupOpen-labelTreatment
Summary
Endothelial progenitor cells derived from and delivered to the renal vasculature may be stimulated to initiate differentiation programs during episodes of injury. It is hypothesized that endothelial progenitor cells from the kidney can transition to a phenotype that promotes endothelial repair.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2024-01-01
- Completion
- 2025-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | endothelial progenitor cell | Cell therapy | — | Other |